Danaher Corporation (DHR) EV/EBIT Ratio: 27.62x
Is Danaher Corporation’s EV/EBIT ratio high or low?
Danaher Corporation's EV/EBIT ratio of 27.62x is in line with its 5-year average of 29.68x, around the middle of its 5-year range (20.11x–44.24x).
As of Thursday, June 11, 2026. 9.87% below its 12-month average of 30.65x.
DHR EV/EBIT Ratio Chart
DHR Average EV/EBIT Ratio Chart
DHR Current vs Average EV/EBIT Ratio Chart
DHR EV/EBIT Ratio Metrics
EV/EBIT RATIO
27.62x
EV/EBIT RATIO AVG TTM
30.65x
EV/EBIT RATIO AVG 3Y
32.50x
EV/EBIT RATIO AVG 5Y
29.68x
EV/EBIT RATIO AVG 10Y
28.55x
EV/EBIT RATIO AVG 15Y
22.94x
EV/EBIT RATIO AVG 20Y
19.96x
CURRENT VS TTM AVG
-9.87%
CURRENT VS 3Y AVG
-15.02%
CURRENT VS 5Y AVG
-6.95%
CURRENT VS 10Y AVG
-3.27%
CURRENT VS 15Y AVG
+20.39%
CURRENT VS 20Y AVG
+38.39%
DHR Competitors' EV/EBIT Ratio
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Danaher Corporation (DHR) | $127.91B | 27.62x | 30.65x | 32.50x | 29.68x |
| CVS Health Corporation (CVS) | $126.81B | 32.55x | 28.87x | 19.89x | 18.76x |
| Bristol-Myers Squibb Company (BMY) | $116.13B | 12.14x | 11.35x | 15.41x | 18.89x |
| Intuitive Surgical, Inc. (ISRG) | $144.79B | 45.37x | 63.25x | 73.01x | 67.77x |
| Vertex Pharmaceuticals Incorporated (VRTX) | $110.59B | 22.87x | 26.41x | 24.92x | 21.76x |
| Pfizer Inc. (PFE) | $149.61B | 14.37x | 12.24x | 29.84x | 23.37x |
| Medtronic plc (MDT) | $102.80B | 19.23x | 23.68x | 24.37x | 26.81x |
| Abbott Laboratories (ABT) | $155.75B | 22.39x | 27.94x | 30.32x | 27.86x |
| Gilead Sciences, Inc. (GILD) | $156.35B | 14.67x | 18.29x | 42.71x | 31.52x |
| Elevance Health Inc. (ELV) | $86.47B | 14.59x | 11.84x | 13.42x | 14.42x |
Danaher Corporation EV/EBIT Ratio Formula & Definition
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Danaher Corporation EV/EBIT Ratio FAQ
- What is the EV/EBIT ratio for Danaher Corporation (DHR)?
- The EV/EBIT ratio for DHR stock is 27.62x.
- Is Danaher Corporation's EV/EBIT ratio high or low?
- Danaher Corporation's EV/EBIT ratio of 27.62x is in line with its 5-year average of 29.68x, around the middle of its 5-year range (20.11x–44.24x).
- What is the TTM average EV/EBIT ratio for Danaher Corporation (DHR)?
- The TTM average EV/EBIT ratio for DHR stock is 30.65x.
- What is the 3Y average EV/EBIT ratio for Danaher Corporation (DHR)?
- The 3Y average EV/EBIT ratio for DHR stock is 32.50x.
- What is the 5Y average EV/EBIT ratio for Danaher Corporation (DHR)?
- The 5Y average EV/EBIT ratio for DHR stock is 29.68x.
- What is the 10Y average EV/EBIT ratio for Danaher Corporation (DHR)?
- The 10Y average EV/EBIT ratio for DHR stock is 28.55x.
- What is the 15Y average EV/EBIT ratio for Danaher Corporation (DHR)?
- The 15Y average EV/EBIT ratio for DHR stock is 22.94x.
- What is the 20Y average EV/EBIT ratio for Danaher Corporation (DHR)?
- The 20Y average EV/EBIT ratio for DHR stock is 19.96x.
Danaher Corporation EV/EBIT Ratio History
| DATE | EV/EBIT RATIO |
|---|---|
| 2026-06-10 | 27.62x |
| 2026-06-09 | 28.27x |
| 2026-06-08 | 27.60x |
| 2026-06-05 | 27.71x |
| 2026-06-04 | 28.03x |
| 2026-06-03 | 26.86x |
| 2026-06-02 | 26.59x |
| 2026-06-01 | 27.10x |
| 2026-05-29 | 27.48x |
| 2026-05-28 | 27.20x |
| 2026-05-27 | 26.18x |
| 2026-05-26 | 26.13x |
| 2026-05-22 | 26.02x |
| 2026-05-21 | 26.20x |
| 2026-05-20 | 25.90x |
| 2026-05-19 | 25.34x |
| 2026-05-18 | 24.91x |
| 2026-05-15 | 24.64x |
| 2026-05-14 | 25.00x |
| 2026-05-13 | 25.20x |
| 2026-05-12 | 25.24x |
| 2026-05-11 | 25.27x |
| 2026-05-08 | 25.91x |
| 2026-05-07 | 26.52x |
| 2026-05-06 | 26.42x |
| 2026-05-05 | 26.38x |
| 2026-05-04 | 26.30x |
| 2026-05-01 | 26.45x |
| 2026-04-30 | 26.97x |
| 2026-04-29 | 26.95x |
| 2026-04-28 | 26.98x |
| 2026-04-27 | 27.20x |
| 2026-04-24 | 26.74x |
| 2026-04-23 | 26.92x |
| 2026-04-22 | 27.67x |
| 2026-04-21 | 29.11x |
| 2026-04-20 | 29.24x |
| 2026-04-17 | 29.64x |
| 2026-04-16 | 29.51x |
| 2026-04-15 | 30.11x |
| 2026-04-14 | 30.18x |
| 2026-04-13 | 29.80x |
| 2026-04-10 | 28.93x |
| 2026-04-09 | 29.40x |
| 2026-04-08 | 29.84x |
| 2026-04-07 | 29.12x |
| 2026-04-06 | 29.28x |
| 2026-04-02 | 29.14x |
| 2026-04-01 | 29.09x |
| 2026-03-31 | 28.93x |
| 2026-03-30 | 28.14x |
| 2026-03-27 | 27.81x |
| 2026-03-26 | 28.71x |
| 2026-03-25 | 28.59x |
| 2026-03-24 | 29.00x |
| 2026-03-23 | 28.98x |
| 2026-03-20 | 28.89x |
| 2026-03-19 | 29.00x |
| 2026-03-18 | 29.19x |
| 2026-03-17 | 29.71x |
| 2026-03-16 | 29.18x |
| 2026-03-13 | 28.61x |
| 2026-03-12 | 28.47x |
| 2026-03-11 | 29.68x |
| 2026-03-10 | 29.71x |
| 2026-03-09 | 30.20x |
| 2026-03-06 | 29.75x |
| 2026-03-05 | 30.65x |
| 2026-03-04 | 31.02x |
| 2026-03-03 | 30.92x |
| 2026-03-02 | 31.20x |
| 2026-02-27 | 31.84x |
| 2026-02-26 | 31.66x |
| 2026-02-25 | 31.69x |
| 2026-02-24 | 31.64x |
| 2026-02-23 | 30.82x |
| 2026-02-20 | 30.64x |
| 2026-02-19 | 30.87x |
| 2026-02-18 | 30.51x |
| 2026-02-17 | 30.22x |
| 2026-02-13 | 31.04x |
| 2026-02-12 | 31.36x |
| 2026-02-11 | 32.03x |
| 2026-02-10 | 31.99x |
| 2026-02-09 | 31.58x |
| 2026-02-06 | 31.58x |
| 2026-02-05 | 31.46x |
| 2026-02-04 | 31.97x |
| 2026-02-03 | 31.58x |
| 2026-02-02 | 32.48x |
| 2026-01-30 | 31.88x |
| 2026-01-29 | 31.98x |
| 2026-01-28 | 32.63x |
| 2026-01-27 | 34.12x |
| 2026-01-26 | 34.24x |
| 2026-01-23 | 34.02x |
| 2026-01-22 | 34.69x |
| 2026-01-21 | 34.95x |
| 2026-01-20 | 33.93x |
| 2026-01-16 | 34.15x |
| 2026-01-15 | 34.67x |
| 2026-01-14 | 34.41x |
| 2026-01-13 | 34.09x |
| 2026-01-12 | 34.55x |
| 2026-01-09 | 34.46x |
| 2026-01-08 | 34.02x |
| 2026-01-07 | 34.09x |
| 2026-01-06 | 34.23x |
| 2026-01-05 | 34.07x |
| 2026-01-02 | 33.41x |
| 2025-12-31 | 33.21x |
| 2025-12-30 | 33.44x |
| 2025-12-29 | 33.44x |
| 2025-12-26 | 33.40x |
| 2025-12-24 | 33.55x |
| 2025-12-23 | 33.46x |
| 2025-12-22 | 33.09x |
| 2025-12-19 | 32.67x |
| 2025-12-18 | 32.60x |
| 2025-12-17 | 32.38x |
| 2025-12-16 | 32.65x |
| 2025-12-15 | 33.16x |
| 2025-12-12 | 32.87x |
| 2025-12-11 | 33.67x |
| 2025-12-10 | 33.41x |
| 2025-12-09 | 32.46x |
| 2025-12-08 | 32.62x |
| 2025-12-05 | 32.86x |
| 2025-12-04 | 32.97x |
| 2025-12-03 | 33.15x |
| 2025-12-02 | 32.90x |
| 2025-12-01 | 32.58x |
| 2025-11-28 | 32.93x |
| 2025-11-26 | 33.15x |
| 2025-11-25 | 33.46x |
| 2025-11-24 | 32.95x |
| 2025-11-21 | 33.01x |
| 2025-11-20 | 32.32x |
| 2025-11-19 | 32.35x |
| 2025-11-18 | 32.76x |
| 2025-11-17 | 32.09x |
| 2025-11-14 | 32.19x |
| 2025-11-13 | 32.19x |
| 2025-11-12 | 31.95x |
| 2025-11-11 | 31.47x |
| 2025-11-10 | 30.86x |
| 2025-11-07 | 30.69x |
| 2025-11-06 | 30.79x |
| 2025-11-05 | 30.99x |
| 2025-11-04 | 31.21x |
| 2025-11-03 | 31.24x |
| 2025-10-31 | 31.42x |
| 2025-10-30 | 31.37x |
| 2025-10-29 | 31.23x |
| 2025-10-28 | 31.62x |
| 2025-10-27 | 32.16x |
| 2025-10-24 | 32.43x |
| 2025-10-23 | 32.39x |
| 2025-10-22 | 31.78x |
| 2025-10-21 | 32.13x |
| 2025-10-20 | 30.49x |
| 2025-10-17 | 32.00x |
| 2025-10-16 | 32.26x |
| 2025-10-15 | 31.59x |
| 2025-10-14 | 31.60x |
| 2025-10-13 | 31.46x |
| 2025-10-10 | 31.09x |
| 2025-10-09 | 31.37x |
| 2025-10-08 | 31.43x |
| 2025-10-07 | 31.96x |
| 2025-10-06 | 32.37x |
| 2025-10-03 | 32.82x |
| 2025-10-02 | 32.18x |
| 2025-10-01 | 32.53x |
| 2025-09-30 | 30.50x |
| 2025-09-29 | 28.81x |
| 2025-09-26 | 28.64x |
| 2025-09-25 | 28.17x |
| 2025-09-24 | 28.79x |
| 2025-09-23 | 29.32x |
| 2025-09-22 | 29.42x |
| 2025-09-19 | 29.82x |
| 2025-09-18 | 30.09x |
| 2025-09-17 | 29.77x |
| 2025-09-16 | 29.42x |
| 2025-09-15 | 29.16x |
| 2025-09-12 | 29.37x |
| 2025-09-11 | 30.07x |
| 2025-09-10 | 29.72x |
| 2025-09-09 | 29.96x |
| 2025-09-08 | 30.56x |
| 2025-09-05 | 30.78x |
| 2025-09-04 | 30.61x |
| 2025-09-03 | 30.67x |
| 2025-09-02 | 31.27x |
| 2025-08-29 | 31.55x |
| 2025-08-28 | 31.48x |
| 2025-08-27 | 31.44x |
| 2025-08-26 | 31.61x |
| 2025-08-25 | 31.82x |
| 2025-08-22 | 32.38x |
| 2025-08-21 | 31.29x |
| 2025-08-20 | 32.33x |
| 2025-08-19 | 32.44x |
| 2025-08-18 | 32.00x |
| 2025-08-15 | 32.26x |
| 2025-08-14 | 32.16x |
| 2025-08-13 | 32.01x |
| 2025-08-12 | 31.54x |
| 2025-08-11 | 30.71x |
| 2025-08-08 | 30.82x |
| 2025-08-07 | 30.54x |
| 2025-08-06 | 30.08x |
| 2025-08-05 | 30.61x |
| 2025-08-04 | 30.39x |
| 2025-08-01 | 30.34x |
| 2025-07-31 | 30.35x |
| 2025-07-30 | 31.30x |
| 2025-07-29 | 31.70x |
| 2025-07-28 | 31.15x |
| 2025-07-25 | 31.51x |
| 2025-07-24 | 31.14x |
| 2025-07-23 | 30.45x |
| 2025-07-22 | 29.35x |
| 2025-07-21 | 29.09x |
| 2025-07-18 | 29.56x |
| 2025-07-17 | 30.22x |
| 2025-07-16 | 30.02x |
| 2025-07-15 | 29.95x |
| 2025-07-14 | 30.64x |
| 2025-07-11 | 31.63x |
| 2025-07-10 | 31.72x |
| 2025-07-09 | 31.09x |
| 2025-07-08 | 31.05x |
| 2025-07-07 | 30.90x |
| 2025-07-03 | 31.40x |
| 2025-07-02 | 31.30x |
| 2025-07-01 | 31.11x |
| 2025-06-30 | 30.61x |
| 2025-06-27 | 30.78x |
| 2025-06-26 | 31.16x |
| 2025-06-25 | 31.09x |
| 2025-06-24 | 30.60x |
| 2025-06-23 | 30.44x |
| 2025-06-20 | 30.45x |
| 2025-06-18 | 30.18x |
| 2025-06-17 | 30.36x |
| 2025-06-16 | 31.11x |
| 2025-06-13 | 31.05x |
| 2025-06-12 | 31.66x |
| 2025-06-11 | 31.61x |
| 2025-06-10 | 31.32x |
| 2025-06-09 | 30.84x |
| 2025-06-06 | 30.40x |
| 2025-06-05 | 29.86x |
| 2025-06-04 | 29.99x |
| 2025-06-03 | 29.84x |
| 2025-06-02 | 29.45x |
| 2025-05-30 | 29.54x |
| 2025-05-29 | 29.62x |
Showing the most recent 260 of 5,031 data points. The chart above shows the full history.
Related Metrics
About Danaher Corporation
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Rainer Blair